NCT04267614View on ClinicalTrials.gov

This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.

CompletedOBSERVATIONAL
Enrollment

1,226

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

December 1, 2018

Study Completion Date

December 1, 2018

Conditions
Arthritis Rheumatoid
Interventions
DRUG

Etanercept

Patients who received etanercept for RA

Trial Locations (1)

Unknown

Pfizer, Baghdad

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY